Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

Vaz, SC; Adam, JA; Delgado Bolton, RC; Vera, P; van Elmpt, W; Herrmann, K; Hicks, RJ; Lievens, Y; Santos, A; Schoder, H; Dubray, B; Visvikis, D; Troost, EGC; de Geus-Oei, LF

Author(s): Vaz, SC; Adam, JA; Delgado Bolton, RC; Vera, P; van Elmpt, W; Herrmann, K; Hicks, RJ; Lievens, Y; Santos, A; Schoder, H; Dubray, B; Visvikis, D; Troost, EGC; de Geus-Oei, LF;
Details: Publication Year 2022-03,Volume 49,Issue #4,Page 1386-1406
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Publication Type: Guideline
Abstract: PURPOSE: 2-[(18)F]FDG PET/CT is of utmost importance for radiation treatment (RT) planning and response monitoring in lung cancer patients, in both non-small and small cell lung cancer (NSCLC and SCLC). This topic has been addressed in guidelines composed by experts within the field of radiation oncology. However, up to present, there is no procedural guideline on this subject, with involvement of the nuclear medicine societies. METHODS: A literature review was performed, followed by a discussion between a multidisciplinary team of experts in the different fields involved in the RT planning of lung cancer, in order to guide clinical management. The project was led by experts of the two nuclear medicine societies (EANM and SNMMI) and radiation oncology (ESTRO). RESULTS AND CONCLUSION: This guideline results from a joint and dynamic collaboration between the relevant disciplines for this topic. It provides a worldwide, state of the art, and multidisciplinary guide to 2-[(18)F]FDG PET/CT RT planning in NSCLC and SCLC. These practical recommendations describe applicable updates for existing clinical practices, highlight potential flaws, and provide solutions to overcome these as well. Finally, the recent developments considered for future application are also reviewed.
Keywords: *Carcinoma, Non-Small-Cell Lung/diagnostic imaging/radiotherapy; Fluorodeoxyglucose F18; Humans; *Lung Neoplasms/diagnostic imaging/radiotherapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography/methods; Ct; Estro, 2-[18f]fdg pet; Lung cancer; Planning; Radiation therapy; Radiotherapy, EANM; Snmmi
Department(s): Cancer Imaging
PubMed ID: 35022844
Publisher's Version: https://doi.org/10.1007/s00259-021-05624-5
Open Access at Publisher's Site: https://doi.org/10.1007/s00259-021-05624-5
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2025-05-09 03:13:02

Last Modified: 2025-05-09 03:13:54